A missense mutation in a ubiquitously expressed protein, vinculin, confers susceptibility to hypertrophic cardiomyopathy

Biochemical and Biophysical Research Communications

Volumn 345, Issue 3, 2006, Pages 998-1003

  Vasile, Vlad C ^a   Ommen, Steve R ^b   Edwards, William D ^b   Ackerman, Michael J ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic   (United States)

Author keywords

Cell biology; Genetics; Hypertrophic cardiomyopathy; Molecular biology; Vinculin

Indexed keywords

VINCULIN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EXON; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MYOFILAMENT; MYOMECTOMY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UBIQUITINATION;

ADULT; AGED; ALTERNATIVE SPLICING; CARDIOMYOPATHY, HYPERTROPHIC; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; VINCULIN;

EID: 33646850881     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.04.151     Document Type: Article

References (29)

1. Vasile V.C., Will M.L., Ommen S.R., Edwards W.D., Olson T.M., and Ackerman M.J. Identification of a metavinculin missense mutation, R975W, associated with both hypertrophic and dilated cardiomyopathy. Mol. Genet. Metab. 87 (2006) 169-174
2. Van Driest S.L., Ellsworth E.G., Ommen S.R., Tajik A.J., Gersh B.J., and Ackerman M.J. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation 108 (2003) 445-451
3. Van Driest S.L., Vasile V.C., Ommen S.R., Will M.L., Gersh B.J., Nishimura R.A., Tajik A.J., and Ackerman M.J. Myosin binding protein C mutations and compound herterozygosity in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 44 (2004) 1903-1910
4. Van Driest S.L., Jaeger M.A., Ommen S.R., Will M.L., Gersh B.J., Tajik A.J., and Ackerman M.J. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 44 (2004) 602-610
5. Bos J.M., Poley R.N., Ny M., Tester D.J., Xu X., Vatta M., Towbin J.A., Gersh B.J., Ommen S.R., and Ackerman M.J. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein and telethonin. Mol. Genet. Metab. 88 (2006) 78-85
6. Bartleson V.B., Stocker J.L., Ommen S.R., Edwards W.D., Towbin J.A., and Ackerman M.J. ZASP: a novel candidate gene in the pathogenesis of hypertrophic cardiomyopathy. PAS 57 (2005) 2371
7. Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., and Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92 (1995) 785-789
8. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
9. Arad M., Seidman J.G., and Seidman C.E. Phenotypic diversity in hypertrophic cardiomyopathy. Human Mol. Genet. 11 (2002) 2499-2506
10. Maron B.J., Seidman J.G., and Seidman C.E. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 44 (2004) 2125-2132
11. Van Driest S.L., Ommen S.R., Tajik A.J., Gersh B.J., and Ackerman M.J. Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo. Clin. Proc. 80 (2005) 463-469
12. Moiseyeva E.P., Weller P.A., Zhidkova N.I., Corben E.B., Patel B., Jasinska I., Koteliansky V.E., and Critchley D.R. Organization of the human gene encoding the cytoskeletal protein vinculin and the sequence of the vinculin promoter. J. Biol. Chem. 268 (1993) 4318-4325
13. Koteliansky V.E., Ogryzko E.P., Zhidkova N.I., Weller P.A., Critchley D.R., Vancompernolle K., Vandekerckhove J., Strasser P., Way M., Gimona M., et al. An additional exon in the human vinculin gene specifically encodes meta-vinculin-specific difference peptide. Cross-species comparison reveals variable and conserved motifs in the meta-vinculin insert. Eur. J. Biochem. 204 (1992) 767-772
14. Belkin A.M., Ornatsky O.I., Kabakov A.E., Glukhova M.A., and Koteliansky V.E. Diversity of vinculin/meta-vinculin in human tissues and cultivated cells. Expression of muscle specific variants of vinculin in human aorta smooth muscle cells. J. Biol. Chem. 263 (1988) 6631-6635
15. Belkin A.M., Ornatsky O.I., Glukhova M.A., and Koteliansky V.E. Immunolocalization of meta-vinculin in human smooth and cardiac muscles. J. Cell Biol. 107 (1988) 545-553
16. Olson T.M., Illenberger S., Kishimoto N.Y., Huttelmaier S., Keating M.T., and Jockusch B.M. Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation 105 (2002) 431-437
17. Rudiger M., Korneeva N., Schwienbacher C., Weiss E.E., and Jockusch B.M. Differential actin organization by vinculin isoforms: implications for cell type-specific microfilament anchorage. FEBS Lett. 431 (1998) 49-54
18. Sharp W.W., Simpson D.G., Borg T.K., Samarel A.M., and Terracio L. Mechanical forces regulate focal adhesion and costamere assembly in cardiac myocytes. Am. J. Physiol. 273 (1997) H546-H556
19. Xu W., Baribault H., and Adamson E.D. Vinculin knockout results in heart and brain defects during embryonic development. Development 125 (1998) 327-337
20. Zemljic-Harpf A.E., Ponrartana S., Avalos R.T., Jordan M.C., Roos K.P., Dalton N.D., Phan V.Q., Adamson E.D., and Ross R.S. Heterozygous inactivation of the vinculin gene predisposes to stress-induced cardiomyopathy. Am. J. Pathol. 165 (2004) 1033-1044
21. Gollob M.H., Green M.S., Tang A.S., Gollob T., Karibe A., Ali Hassan A.S., Ahmad F., Lozado R., Shah G., Fananapazir L., Bachinski L.L., and Roberts R. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N. Engl. J. Med. 344 (2001) 1823-1831
22. Blair E., Redwood C., Ashrafian H., Oliveira M., Broxholme J., Kerr B., Salmon A., Ostman-Smith I., and Watkins H. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum. Mol. Genet. 10 (2001) 1215-1220
23. Nakao S., Takenaka T., Maeda M., Kodama C., Tanaka A., Tahara M., Yoshida A., Kuriyama M., Hayashibe H., Sakuraba H., et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N. Engl. J. Med. 333 (1995) 288-293
24. Nishino I., Fu J., Tanji K., Yamada T., Shimojo S., Koori T., Mora M., Riggs J.E., Oh S.J., Koga Y., Sue C.M., Yamamoto A., Murakami N., Shanske S., Byrne E., Bonilla E., Nonaka I., DiMauro S., and Hirano M. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 406 (2000) 906-910
25. Sugie K., Yamamoto A., Murayama K., Oh S.J., Takahashi M., Mora M., Riggs J.E., Colomer J., Iturriaga C., Meloni A., Lamperti C., Saitoh S., Byrne E., DiMauro S., Nonaka I., Hirano M., and Nishino I. Clinicopathological features of genetically confirmed Danon disease. Neurology 58 (2002) 1773-1778
26. Van den Hout H., Reuser A.J., Vulto A.G., Loonen M.C., Cromme-Dijkhuis A., and Van der Ploeg A.T. Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet 356 (2000) 397-398
27. Sachdev B., Takenaka T., Teraguchi H., Tei C., Lee P., McKenna W.J., and Elliott P.M. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 105 (2002) 1407-1411
28. Arad M., Maron B.J., Gorham J.M., Johnson Jr. W.H., Saul J.P., Perez-Atayde A.R., Spirito P., Wright G.B., Kanter R.J., Seidman C.E., and Seidman J.G. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N. Engl. J. Med. 352 (2005) 362-372
29. Borgon R.A., Vonrhein C., Bricogne G., Bois P.R., and Izard T. Crystal structure of human vinculin. Structure 12 (2004) 1189-1197